Aimmune Therapeutics Inc
(NASDAQ : AIMT)

( )
AIMT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.61%93.101.3%$988.29m
BIIBBiogen Inc.
-2.52%224.401.3%$650.41m
AMGNAmgen Inc.
-0.81%178.301.3%$468.17m
GILDGilead Sciences, Inc.
-0.38%62.800.9%$434.85m
ILMNIllumina, Inc.
-2.34%314.523.5%$280.91m
REGNRegeneron Pharmaceuticals, Inc.
-1.07%340.462.6%$279.54m
VRTXVertex Pharmaceuticals Incorporated
-1.59%172.581.9%$238.29m
ALXNAlexion Pharmaceuticals, Inc.
-1.72%130.092.0%$169.34m
EXASExact Sciences Corporation
1.27%95.1325.3%$167.52m
AAgilent Technologies, Inc.
0.30%75.791.6%$145.62m
SRPTSarepta Therapeutics, Inc.
0.06%118.1614.7%$133.09m
ONCESpark Therapeutics, Inc.
0.06%110.6711.2%$117.72m
INCYIncyte Corporation
-2.51%73.522.5%$96.42m
IONSIonis Pharmaceuticals, Inc.
-2.23%73.338.3%$95.85m
BMRNBioMarin Pharmaceutical Inc.
-0.59%85.494.3%$92.14m

Company Profile

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.